JOHNSON JOHN 4
4 · Xeris Biopharma Holdings, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Johnson John H
Director
Transactions
- Award
Common Stock
2025-06-04+50,000→ 940,983 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders.